Synopsis
Synopsis
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Antergan
2. Cyproheptadine
3. Dihexazin
4. Periactin
5. Peritol
6. Viternum
1. 969-33-5
2. Cyproheptadine Hcl
3. Periactin Hydrochloride
4. Anarexol
5. Cipractin
6. Nuran
7. Antegan
8. Peritol
9. Periactin Syrup
10. Component Of Dronactin
11. Cyproheptadine (hydrochloride)
12. Cyproheptadine Hydrochloride Anhydrous
13. Cyproheptadiene Hydrochloride
14. 41354-29-4
15. Nsc-169911
16. Cyproheptadine Hydrochloride Sesquihydrate
17. Cyproheptadine Hydrochloride (anhydrous)
18. Cpd000058431
19. Mls000028462
20. Chebi:59695
21. 0s9323mct0
22. 4-(5h-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine Hydrochloride
23. Periactine
24. Nsc-759282
25. Smr000058431
26. 4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine Hydrochloride
27. Cyproheptadine (hydrochloride Sesquihydrate)
28. 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine Hydrochloride
29. 1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine;hydrochloride
30. Periactinol (van)
31. Contrallerg
32. Kulinet
33. Kyliver
34. Sialotin
35. Vinorex
36. Istam
37. Periactinol Hydrochloride
38. Cyproheptadine Chlorhydrate
39. 4-(5h-dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine Hydrochloride
40. 4-(5h-dibenzo[a,d]cyclohepten-5-ylidine)-methylpiperidine Hydrochloride
41. Cycloheptadine Hydrochloride
42. Cyproheptadine Hydrochloride Hydrate
43. Vufb3511
44. Sr-01000003077
45. Einecs 213-535-1
46. Nsc 169911
47. C21h21n.hcl
48. Unii-0s9323mct0
49. 4-(5-dibenzo[a,e]cycloheptatrienylidene)piperidine Hydrochloride
50. Ai3-26940
51. 1-methyl-4-(5-dibenzo[a,e]cycloheptatrienylidene)piperidine Hydrochloride
52. 4-(dibenzo[2,1-b:1',2'-e][7]annulen-11-ylidene)-1-methylpiperidine;hydrochloride
53. Cycloheptadine Hcl
54. Prestwick_139
55. Opera_id_383
56. Cypoheptadine Hydrochloride
57. Cyproheptadine-hydrochloride
58. Piperidine, 4-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-, Hydrochloride
59. Chembl1716
60. Schembl41842
61. Mls001077277
62. Mls001424281
63. Mls002222173
64. Regid_for_cid_13770
65. Cyproptadine Hydrochloride,(s)
66. Dtxsid5042586
67. Hy-b0366a
68. Hms1568e08
69. Hms3414j05
70. Hms3678j03
71. Pharmakon1600-01505973
72. Bcp34399
73. Cyproheptadine Hydrochloride (anh.)
74. Tox21_500246
75. Anhydrous Cyproheptadine Hydrochloride
76. Mfcd00012538
77. Nsc169911
78. Nsc759282
79. S2044
80. Akos015905305
81. Ccg-101144
82. Lp00246
83. Nc00394
84. Cyproheptadine Hydrochloride (periactin)
85. Ncgc00093708-01
86. Ncgc00093708-02
87. Ncgc00260931-01
88. Ac-15790
89. As-14697
90. Cyproheptadine Hydrochloride [who-dd]
91. Eu-0100246
92. Ft-0603147
93. Sw196450-4
94. C 6022
95. C77331
96. Wln: L C676 Byj Bu- Dt6n Dytj A1 &gh
97. Sr-01000003077-2
98. Sr-01000003077-4
99. Sr-01000003077-9
100. W-106308
101. Cyproheptadine Hydrochloride 100 Microg/ml In Methanol
102. Q27126856
103. Piperidine,d]cyclohepten-5-ylidene)-1-methyl-, Hydrochloride
104. 4-(5h-dibenzo [a,d]cyclohepten-5-ylidene)-1-methylpiperidine Hydrochloride
105. 4-(5h-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidinehydrochloride
106. 4-(5h-dibenzo[a,d]cyclohepten-5-yli Dine)-methylpiperidine Hydrochloride
107. 1-methyl-4-(2-tricyclo[9.4.0.0^{3,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine;hydrochloride
108. 1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine Hydrochloride
Molecular Weight | 323.9 g/mol |
---|---|
Molecular Formula | C21H22ClN |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 0 |
Exact Mass | 323.1440774 g/mol |
Monoisotopic Mass | 323.1440774 g/mol |
Topological Polar Surface Area | 3.2 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 423 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Cyproheptadine hydrochloride |
PubMed Health | Cyproheptadine Hydrochloride (By mouth) |
Drug Classes | Respiratory Agent |
Drug Label | Cyproheptadine HCl USP, is an antihistaminic and antiserotonergic agent.Cyproheptadine hydrochloride USP is a white to slightly yellowish crystalline solid, with a molecular weight of 350.89, which is soluble in water, freely soluble in methanol, spa... |
Active Ingredient | Cyproheptadine hydrochloride |
Dosage Form | Tablet; Syrup |
Route | Oral |
Strength | 4mg; 2mg/5ml |
Market Status | Prescription |
Company | Lyne; Corepharma; Stason Pharms; Ivax Sub Teva Pharms; Pharm Assoc; Par Pharm |
2 of 2 | |
---|---|
Drug Name | Cyproheptadine hydrochloride |
PubMed Health | Cyproheptadine Hydrochloride (By mouth) |
Drug Classes | Respiratory Agent |
Drug Label | Cyproheptadine HCl USP, is an antihistaminic and antiserotonergic agent.Cyproheptadine hydrochloride USP is a white to slightly yellowish crystalline solid, with a molecular weight of 350.89, which is soluble in water, freely soluble in methanol, spa... |
Active Ingredient | Cyproheptadine hydrochloride |
Dosage Form | Tablet; Syrup |
Route | Oral |
Strength | 4mg; 2mg/5ml |
Market Status | Prescription |
Company | Lyne; Corepharma; Stason Pharms; Ivax Sub Teva Pharms; Pharm Assoc; Par Pharm |
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
Antipruritics
Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-15
Pay. Date : 2012-11-26
DMF Number : 3293
Submission : 1978-09-13
Status : Active
Type : II
Registration Number : 220MF10143
Registrant's Address : Strada Rivoltana Km 6/7 20053 Rodano Milano Italy
Initial Date of Registration : 2008-06-10
Latest Date of Registration : --
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-04-23
Pay. Date : 2013-04-09
DMF Number : 3524
Submission : 1979-02-08
Status : Active
Type : II
Registration Number : 220MF10221
Registrant's Address : Via Bissone, 5, 20021-Baranzate, Milano, Italy
Initial Date of Registration : 2008-11-04
Latest Date of Registration : --
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-28
Pay. Date : 2012-12-19
DMF Number : 25456
Submission : 2011-10-10
Status : Active
Type : II
Date of Issue : 2022-06-15
Valid Till : 2025-07-14
Written Confirmation Number : WC-0183nA2
Address of the Firm : Unit -II, Plot No.79,\r\n\r\nJawaharlal Nehru Pharmacity,\r\n\r\nThanam Village, Parawada MandaI,\r\nVisakhapatnam District,-531019,\r\nAndhra Pradesh, India.\r\n
NDC Package Code : 66577-014
Start Marketing Date : 2018-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3382
Submission : 1978-11-02
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
KT-110, a new and innovative approach based on dual receptor targeting. Study evaluates the efficacy, safety and tolerance of KT-110, a combination of 2 molecules protected by a compositional patent, on alcohol consumption in patients suffering from severe alcoholism.
Lead Product(s): Cyproheptadine Hydrochloride,Prazosin Hydrochloride
Therapeutic Area: Psychiatry/Psychology Brand Name: KT-110
Study Phase: Phase IIProduct Type: Small molecule
Sponsor: ECSOR
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable August 30, 2021
Lead Product(s) : Cyproheptadine Hydrochloride,Prazosin Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : ECSOR
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : KT-110, a new and innovative approach based on dual receptor targeting. Study evaluates the efficacy, safety and tolerance of KT-110, a combination of 2 molecules protected by a compositional patent, on alcohol consumption in patients suffering from seve...
Brand Name : KT-110
Molecule Type : Small molecule
Upfront Cash : Not Applicable
August 30, 2021
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?